Dr. Pecora has been with OMI since its inception, according to a Jan. 23 release announcing his appointment. During his time there, he has overseen the development of OMI’s management services and site research organization businesses.
OMI has also developed value-based care programs in pulmonology, ophthalmology and breast cancer under Dr. Pecora’s leadership. These programs aim to maintain clinical outcomes for patients while lowering the cost for health plans and government payers, the release said.
Dr. Pecora is the founder and chairman of oncology technology company Cota. He has also conducted research funded by the National Cancer Institute and the AHEPA Research Foundation.
OMI also named Benjamin Schoen executive vice president and chief business officer.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.